Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The aims of this trial are to evaluate the efficacy and tolerability of pemetrexed +
paclitaxel in patients with recurrent/advanced follicular, papillary or anaplastic thyroid
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Schleswig-Holstein University of Schleswig-Holstein